Dongchuan Yu, Southeast University, China Updates Copyright 2022 Li, Xu, Pang, Zhao, Zhang, Li, Li, Duan and Zhu
The platform cannot guarantee that any individual will be approved for treatment
NAD (nicotinamide adenine dinucleotide) helps the mitochondria make energy
However, the $2 billion+ deal between Hansoh and Merck highlights their strong confidence in the market prospects of HS-10535, adding fuel to the fire in the GLP-1 drug market
He also reports grants and personal fees as a consultant and/or speaker from Amgen, AstraZeneca, Boehringer Ingelheim, Faes Farma, Fresenius, Janssen Pharmaceuticals, Eli Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer, Sanofi, Shire, and UCB
Cell 56 , 414424 (2014)